The Big Short: Drug Shortage Impact & Innovations for Hospitalists
When lorazepam vanished overnight, hospitalists had to pivot. In this case‑driven, you adapt phenobarbital‑first care for alcohol withdrawal, transition seizure rescue to intranasal midazolam or IV levetiracetam, and revise AF order sets when IV beta‑blockers and diltiazem run short. You also deprescribe judiciously and design system fixes—multisourcing, reliability‑weighted purchasing, and real‑time stock dashboards—to strengthen care under shortage pressure.
Availability
On-Demand
Expires on Apr 30, 2027
Cost
Member: $0.00
Non-Member: $55.00
Credit Offered
0.75 CME Credit
0.75 ABIM-MOC Point
0.75 Participation Credit
  • Overview
  • Faculty
  • Accreditation
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. Articulate three common reasons for drug shortages matched with 3 system level improvement opportunities providers can advocate for to reduce future drug shortages.
  2. Illustrate at least 2 new care pathways and associated outcomes that have emerged from benzodiazepine shortages.
  3. Formulate a hospital atrial fibrillation or arrythmia contingency care plan or "order set" in the (currently hypothetical) setting of simultaneous drug shortages of both intravenous beta blocker and calcium channel blocker therapy.
  4. Predict future state oral antibiotic shortages based on newly gained supply chain knowledge and list 2 alternative antibiotics for use in community acquired pneumonia, skin and soft tissue infections, and urinary tract infections.
Faculty
  • Kirsten Nieto, MD
  • Mary Gilmer

Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.

 

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75  MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IOS App Download Powered By